上海金畔生物科技有限公司为生命科学和医药研发人员提供生物活性分子抑制剂、激动剂、特异性抑制剂、化合物库、重组蛋白,专注于信号通路和疾病研究领域。
RPR121056 (Synonyms: APC)
RPR121056 (APC) 是通过 CYP3A4 产生的 Irinotecan (CPT-11) 的代谢产物。Irinotecan (CPT-11) 是一种抗肿瘤药,可抑制 I 型拓扑异构酶 (topoisomerase type I),引起细胞死亡,并用于大肠癌的研究。Irinotecan 也能直接抑制 AChE。
RPR121056 Chemical Structure
CAS No. : 181467-56-1
规格 | 是否有货 | ||
---|---|---|---|
100 mg | 询价 | ||
250 mg | 询价 | ||
500 mg | 询价 |
* Please select Quantity before adding items.
生物活性 |
RPR121056 (APC) is a metabolite of Irinotecan (CPT-11), which is generated by CYP3A4. Irinotecan (CPT-11) is an antineoplastic agent that inhibits topoisomerase type I, causing cell death, and is widely used in the treatment of colorectal cancer. Irinotecan also directly inhibits AChE[1]. |
IC50 & Target |
Topoisomerase type I[1]; AChE[1] |
---|---|
分子量 |
618.68 |
Formula |
C33H38N4O8 |
CAS 号 |
181467-56-1 |
运输条件 |
Room temperature in continental US; may vary elsewhere. |
储存方式 |
Please store the product under the recommended conditions in the Certificate of Analysis. |
参考文献 |
|
所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务